DOSSIER · 13F Holders · Q2 2026Healthcare · Pharmaceutical Preparations
LGND
LIGAND PHARMACEUTICALS INC
430 institutions still hold LIGAND PHARMACEUTICALS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 53220K504·Pharmaceutical Preparations·430 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
430 institutions reported LGND in Q2 2026. BlackRock, Inc. leads at 20.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 22
410 more holders available. Log in →